Funding Opportunities

• Initiation of a Mental Health Family Navigator Model to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R01)
  (PAR-17-265)
  National Institute of Mental Health
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
• Pilot Studies to Test the Initiation of a Mental Health Family Navigator to Promote Early Access, Engagement and Coordination of Needed Mental Health Services for Children and Adolescents (R34)
  (PAR-17-266)
  National Institute of Mental Health
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Modeling of Infectious Disease Agent Study Research Projects (R01)
  (PAR-17-267)
  National Institute of General Medical Sciences
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates.
• Planning Grants for Clinical Trials of High Relevance to the NIGMS Mission (R34)
  (PAR-17-268)
  National Institute of General Medical Sciences
  Application Receipt Date(s): August 7, 2017; August 1, 2018; August 1, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01)
  (PAR-17-269)
  National Human Genome Research Institute
  Application Receipt Date(s): Applications are accepted by continuous receipt)by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• NIDDK Central Repositories Non-renewable Sample Access (X01)
  (PAR-17-270)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): July 31, 2017; October 31, 2017; March 2, 2018; June 29, 2018; October 30, 2018; March 1, 2019; June 28, 2019; October 31, 2019; March 3, 2020; and June 30, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Pilot Effectivness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R34)
  (PAR-17-271)
  National Institute of Mental Health
  Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
• Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01)
  (PAR-17-272)
  National Institute of Mental Health
  Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
• Mechanistic Ancillary Studies to Ongoing Interventional Clinical Trials (R01)
  (RFA-AR-18-002)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): August 7, 2017; December 4, 2017; April 2, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Mechanistic Ancillary Studies to Ongoing Interventional Clinical Trials (R21)
  (RFA-AR-18-003)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  Application Receipt Date(s): August 7, 2017; December 4, 2017; April 2, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Cystic Fibrosis Research and Translation Center (P30)
  (RFA-DK-17-007)
  National Institute of Diabetes and Digestive and Kidney Diseases
  Application Receipt Date(s): July 20, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Data Coordinating Center for the NICHD Neonatal Research Network (U24)
  (RFA-HD-18-010)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): June 30, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R01)
  (RFA-MH-18-300)
  National Institute of Mental Health
  National Institute on Drug Abuse
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): September 6, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Role of Myeloid Cells in Persistence and Eradication of HIV-1 Reservoirs from the Brain (R21)
  (RFA-MH-18-301)
  National Institute of Mental Health
  National Institute on Drug Abuse
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): September 6, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.